Good morning, ladies and gentlemen, and welcome to the Fourth Quarter 2020 TransDigm Group Incorporated Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Jaimie Stemen, Manager, Investor Relations. You may begin.

Thank you and welcome to TransDigm’s fiscal 2020 fourth quarter earnings conference call. Presenting on the call this morning are TransDigm’s Executive Chairman, Nick Howley; President and Chief Executive Officer, Kevin Stein; and Chief Financial Officer, Mike Lisman. Please visit our website at transdigm.com to obtain a supplemental slide deck and call replay information. Before we begin, the company would like to remind you that statements made during this call, which are not historical in fact are forward-looking statements. For further information about important factors that could cause actual results to differ materially from those expressed or implied in those forward-looking statements, please refer to the company’s latest filings with the SEC available through the Investors section of our website or at sec.gov. The company would also like to advise you that during the course of the call, we will be referring to EBITDA, specifically EBITDA as defined, adjusted net income and adjusted earnings per share, all of which are non-GAAP financial measures. Please see the tables and related footnotes in the earnings release for a presentation of the most directly comparable GAAP measures and applicable reconciliations. I will now turn the call over to Nick.

Good morning, and thanks to everyone for calling in. As usual, I’ll start off with a quick overview of our strategy, then a summary of a few significant items in the quarter and next year, and then Kevin and Mike will expand and give a little more color. First, I’d like to start with a short tribute to my original and long-term business partner at TransDigm and long-term friend, Doug Peacock. Doug passed away this quarter at 83 years old. We worked together for 30 years with various business roles between us; as boss, mentor, partner, advisor and long-term friends. We formed the plan for TransDigm in Doug’s basement outside of Princeton, New Jersey in 1992. Doug was involved until almost the end and a participant in almost every major decision along the way. It’s been one hell of a ride and continues to be. Doug lived a good full life and we will miss his advice and guidance. He has been a key part of our consistent strategy, so it’s only right that we jump into that next. Note the remarkable consistency over the last 20 years. Doug has been a key part of that. To reiterate, we are unique in the industry in both the consistency of our strategy in good and bad times, as well as our steady focus on intrinsic shareholder value creation through all phases of the aerospace cycle. Our long-standing goal is to give our shareholders private equity-like returns with the liquidity of a public market. To do this, we must stay focused on both the details of value creation as well as careful allocation of our capital. To summarize, here are some of the reasons why we believe this. About 90% of our net sales are generated by proprietary products and over three quarters of our net sales come from products for which we believe we are the sole-source provider. Most of our EBITDA comes from aftermarket revenues, which typically have significantly higher margins and over any extended period of time provide relative stability in downturns. The commercial aftermarket revenue, typically the largest and most profitable portion of our business, dropped sharply in Q3 as we expected due to the steep decline in air travel and though the commercial aftermarket picked up some in Q4, it’s still off substantially. Sharp drops have occurred in the past during severe shocks, though not to this magnitude and likely duration. Simply stated, our commercial aftermarket will recover as people worldwide start to fly more, though not necessarily in lockstep. This is starting to happen slowly, but the rate of recovery has been slowed down by the recent resurgence in COVID infections and the timing of the recovery is far from clear. We follow a long-term strategy. Specifically, we own and operate proprietary aerospace businesses with significant aftermarket content. Second, we utilize a simple, well-proven value-based operating methodology. Third, we have a decentralized organizational structure and a unique compensation system closely aligned with shareholders. Fourth, we acquire businesses that fit this strategy and where we see a clear path to PE-like returns. And fifth, our capital structure and allocation are a key part of our value creation methodology. As you saw from our earnings release, we had decent performance in Q4, but are still in a very tough commercial aerospace market environment. On the positive side, our revenue and EBITDA as defined were up sequentially, that is versus Q3, about 15% and 17%, respectively, with puts and takes roughly in line with the planning scenario we used for sizing. Obviously, due to the COVID impact on flying, both are down substantially versus the prior year Q4. To roughly frame the Q3 and Q4 revenues combined versus our planning assumptions, the commercial aftermarket wasn’t quite as bad. The commercial OEM was a little worse, and our defense business was not quite as strong due to some Q3 timing issues. Defense businesses, however, were up substantially sequentially, that is versus Q3, and up about 7% versus the prior year Q4. Defense bookings were ahead of shipments for the year. In addition to safety, the two most important items we focused on continued to be reducing and managing our costs. As I’ve said before, Kevin and his team did an outstanding job of reducing costs quickly. Our revenues were down in the second quarter about 30% versus the prior year second quarter, with some additional cost reductions in Q4. Our run rate costs are now also down by about the same amount. The mix impact of low commercial aftermarket revenues continues to impact our margin, but we have been able to mitigate part of this impact. Second, assuring liquidity, we raised an additional $1.5 billion at the beginning of the third quarter. The money was an insurance policy for uncertain times. It’s unlikely we will need it, but heading into a storm, we filled our fuel tanks as full as we could at a reasonable price. We continue to generate cash in Q4. We generated over $200 million of positive cash flow and closed the quarter with over $4.7 billion in cash. Mike will give more detail here. Absent some large additional dislocations or shutdowns, we should come out of this with very substantial firepower. We continue to look at possible M&A opportunities and are always attentive to our allocation. Both the M&A and capital markets are always difficult to predict, especially during uncertain times like these. Acquisition opportunities in the last quarter were still slow, but we did start to see some modest pickup in activity. We are still actively looking for opportunities that fit our model. In general, with respect to our capital allocation, we still tend to lean towards caution, but we feel a little more optimistic than we did in Q3. We continue to review the Esterline portfolio of businesses. We are investigating the sale of a few less proprietary defense businesses that don’t fit as well with our consistent long-term strategy. If they are all sold, the go-forward revenue might decrease by roughly $250 million to $300 million. The EBITDA margins on these businesses are significantly lower than our average, so the EBITDA impact would not be proportional. At this point, I can’t speculate if we will sell all these businesses or not, but we are actively considering the possibility. Heading into our new fiscal year, we will not give 2021 guidance at this time. When the smoke clears enough for us to feel more confident, we’ll reinstate the guidance. Though we are hopeful that we have bottomed out, there is still just too much uncertainty around commercial air travel, the recent increases in COVID infection rates, the timing of vaccines, the political situation and various related issues. In general, we are planning to keep a very tight control on expenses and hold our organization roughly flat, but it’s just too unclear to know exactly at this point. A few clarifications on some of the 2021 set points. The EBITDA margin as defined for next year is dependent on the rate of recovery in the commercial aftermarket revenue among other factors. For planning purposes, we are assuming a pickup in the second half of the year. Given the recent surge in COVID cases and the uncertainties I mentioned above, we hope and intend to be cautious in our planning, but we just don’t know. Secondly, operating cash flow that is EBITDA minus CapEx and interest and cash taxes, as we traditionally define it, is more in the range of 40% plus a little of the EBITDA as adjusted. This is partially offset by some other conservative assumptions that Mike will review in more detail. We believe we are about as well positioned as we can be for right now. We’ll watch the market develop and react accordingly. And now, let me hand this over to Kevin to review our recent performance and to talk a little more about 2021.

Thanks, Nick. Today I will first provide my regular review of results by key market and profitability of the business for the quarter and then cover fiscal 2021 outlook and some COVID-19 related topics. Q4 was a challenging quarter that closed out our fiscal 2020 against the backdrop of a continued slowdown across the commercial aerospace industry and a difficult global economy. In Q4, we continued to see a significant unfavorable impact on our business from the pandemic as demand for travel has remained depressed. Despite these headwinds, I am pleased that we were able to achieve a Q4 EBITDA as defined Margin of 42.4%, which was a sequential improvement from our Q3 EBITDA as defined Margin, and in spite of the mix impact of low commercial aftermarket sales. Achieving this Q4 margin was primarily a result of our quick preemptive cost reduction actions and continued focus on our operating strategy. Now, we will review our revenues by market category. For the remainder of the call, I will provide color commentary on a pro forma basis compared to the prior year period in 2019, that is assuming we own the same mix of businesses in both periods. In the commercial market, which typically makes up close to 65% of our revenue. We will split our discussion into OEM and aftermarket. Our total commercial OEM market revenue declined approximately 42% in Q4, and approximately 23% for full year fiscal 2020, when compared with prior year periods. The pandemic has caused a significant negative impact on the commercial OEM market. We are under the assumption that demand for our commercial OEM products will continue to be significantly reduced during fiscal 2021 due to reductions in OEM production rates and the airlines deferring or canceling new aircraft orders. Longer term, the impact of COVID-19 is fluid and continues to evolve, but we anticipate significant negative impacts on our commercial OEM end market for some uncertain period of time. On a positive note, it is encouraging that the MAX is moving closer to re-certification in several countries, although the near-term impact to our business will likely be minimal given the low build rates. Now, moving to our commercial aftermarkets business discussion. Total commercial aftermarket revenues declined by approximately 50% in Q4 and approximately 22% for full year fiscal 2020 when compared with prior year periods. In the quarter, the decline in the commercial transport aftermarket was primarily driven by decreased demand in the passenger and interior sub-markets. There was also a decline in the commercial transport freight market, but at a less impactful rate. Our quarterly commercial aftermarket bookings were down in line with observed revenue passenger mile declines as a result of the decrease in air travel demand and uncertainties surrounding COVID. Q4 did demonstrate sequential bookings improvement, although modest. The decline in demand for air travel began late in our Q2 as global restrictions on business and shelter in place orders went into effect in response to the pandemic. This led to a significant reduction in global flight capacity and parked aircraft across the world. Certain markets have reopened, while others particularly international markets remained closed or are enforcing strict quarantines. Airlines have added back some flight capacity and there have been relatively steady increases in global passenger travel since its trough in April, but it has been a slow recovery thus far. Recent resurgences of global COVID-19 cases and renewed lockdowns in certain countries along with the end of the summer leisure travel season have also compounded the slow recovery. Recent vaccine news is certainly encouraging and should drive recovery; however, the timing of vaccine approval and roll-out is still not clear. Considering these variables, the shape and speed of the recovery remains uncertain. To touch on a few key points of consideration, global revenue passenger miles are still at unprecedented lows; though off of the bottom, as a result of the pandemic. IATA recently forecast a 66% decrease in revenue passenger miles in calendar year 2020 compared with 2019. Cargo demand was weaker prior to the COVID-19 crisis, as FTKs have declined from an all-time high in 2017; however, a loss of passenger belly cargo due to flight restrictions and reduced passenger demand has helped cargo operations to be impacted to a less extent by COVID-19 than commercial travel. Business jet utilization data was pointing to stagnant growth before this downturn. Now during the pandemic, and in the aftermath, the outlook for business jets remains unpredictable as business jet flights are rebounding, but due to personal and leisure travel as opposed to business travel. And now that we have exited the summer leisure travel season and face the winter season, the sustainability of this trend is especially difficult to foresee. Although the long-term impacts of the pandemic are hard to predict, we do believe the commercial aftermarket will recover. As long as air traffic continues to improve, clearly a COVID vaccine would accelerate this. We believe the world will once again embrace travel in ever growing numbers, but for now, the timing of the recovery is uncertain. In the meantime, we will continue to make the necessary business decisions and remain focused on our value drivers. Now, let me speak about our defense market which is typically about 35% of our total revenue. The defense market which includes both OEM and aftermarket revenues grew by approximately 7% in Q4, and approximately 1% for full year 2020 when compared with prior year periods. As a reminder, we are lapping tough prior-year comparisons as our defense revenue accelerated in most of fiscal year 2019. Year-to-date defense bookings were up high single digits and have solidly outpaced year-to-date sales. Sequentially, quarterly defense sales grew over 20% quarter-to-quarter, but as we have said many times defense sales and bookings can be lumpy. We continue to expect our defense business to expand due to the strength of the current order book. Now, moving to profitability. I’m going to talk primarily about our operating performance or EBITDA as defined. EBITDA as defined of about $498 million for Q4 was down 30% versus prior Q4. On a full year basis, EBITDA as defined was about $2.28 billion, down 6% from the prior year. EBITDA as defined margin in the quarter was approximately 42.4%. I am pleased that despite the disrupted commercial aerospace industry we were able to expand our EBITDA as defined margin by almost 100 basis points sequentially. We were able to achieve such an EBITDA as defined margin primarily as a result of our stringent cost mitigation efforts and consistent focus on our operating strategy. Our COO, Jorge Valladares, and really the entire operations and business unit team structure that we have provided strong leadership during this very difficult time. Now, moving to our outlook for 2021. As Nick previously mentioned, we will not provide fiscal 2021 sales, EBITDA as defined and net income guidance at this time. We will look to reinstate guidance when there is less uncertainty and we have a clearer picture of the future. Currently, we expect COVID-19 to continue to have a significant adverse impact on our financial results during fiscal 2021, under the assumption that both our commercial OEM and aftermarket customer demand will remain depressed due to lower worldwide air travel, although recent news of an effective vaccine could impact these assumptions quite favorably. As for the defense market, customer demand here is more stable and we feel comfortable giving some color on expectations. We currently expect Defense revenue growth in the low-single digit to mid-single digit percent range for fiscal 2021 versus prior year. Given the uncertainty in the market channels, we are not providing an expected dollar range for EBITDA as defined for the new fiscal year. We assume a steady increase in commercial aftermarket revenue going forward and expect full year fiscal 2021 EBITDA margin to be roughly in the area of 44%, which could be higher or lower based on the rate of commercial aftermarket recovery. Barring any other substantial disruption of the commercial aerospace industry recovery, we anticipate EBITDA margins will move up throughout the year with Q1 being the lowest and sequentially lower than Q4. As in past years with roughly 10% less working days than the subsequent quarters, fiscal year 2021 Q1 revenues, EBITDA, EBITDA margins are anticipated to be lower than the other three quarters of fiscal year 2021, roughly in proportion to the lower working days. Additionally, as discussed on the Q3 earnings call, many of our businesses have taken the opportunity to explore new business opportunities by working on developing highly engineered solutions for emerging needs arising from COVID, including antiviral or antimicrobial technologies, air purification and touchless technologies, to name a few. A cross-TransDigm team is in place, led by Joel Reiss, one of our most experienced executive vice presidents, to help drive this effort and is continuing to look for opportunities and will update in the future. Mike will provide details on other fiscal 2021 financial assumptions. Let me conclude by stating that, although fiscal 2020 was a challenging year, it is a testament to our ability to expertly execute through difficult and unexpected circumstances. I am very pleased with the speed at which TransDigm has responded to the unprecedented pandemic taking immediate actions to protect employees from the spread of the virus while also dealing with the disruption impacting the broader commercial aerospace industry. There is still much uncertainty about the commercial aerospace market recovery; however, we have a strong tenured management team that continues to remain agile and ready to act as necessary. We are not taking our foot off the gas. The team is focused on controlling what we can control while also monitoring the ongoing developments in the commercial aerospace industry and ensuring that we are ready to respond to the demand as it comes back. I have the utmost confidence that through our swift cost mitigation efforts and focus on our operating strategy, the company will emerge more strongly from the ongoing weakness in our primary commercial end markets. We look forward to 2021 and the opportunity to create value for our stakeholders. With that, I’ll hand it over to our CFO, Mike Lisman.

Good morning, everyone. I’m going to quickly hit on a few additional financial matters for the 2020 fiscal year that just completed and also our expectations for the upcoming fiscal ‘21. First, for the full ‘20 fiscal year, you can see the details on revenue, EBITDA and EPS in the press release for today, so I’m not going to rehash it. On the taxes, our FY ‘20 GAAP and cash rates were about 12% and the adjusted rate was about 19%. These were both aided by the Cares Act. On cash and liquidity, we ended the year with approximately $4.7 billion of cash on the balance sheet and our net debt to EBITDA ratio was 6.8 times. Assuming air travel remains depressed, this ratio will continue ticking up in the coming quarters as the stronger pre-COVID quarters roll-out of the LTM EBITDA computation. Next on the FY ‘21 expectations; we aren’t giving full guidance as Nick and Kevin mentioned, but I’ll highlight quickly just a few additional financial assumptions. Interest expense is expected to be in the ballpark of $1.08 billion for the year and this equates to a weighted average interest rate of about 5.2%. On taxes, our ‘21 GAAP cash and adjusted rates are all anticipated to be in the range of 18% to 22%. And on the share count, we expect our weighted average shares outstanding to increase by about 1 million to 58.4 million shares assuming no buybacks occurred during the fiscal year. Similar to prior years, the increase in the shares outstanding is driven by employee stock options divested at the end of FY ‘20. With regard to liquidity in ‘21, we expect to continue running free cash flow positive throughout the year. There has been some confusion on the FY ‘21 cash guide that we gave in the call slides for today, so just a few quick words to hopefully alleviate the confusion. As we would traditionally define our free cash flow from operations at TransDigm, which is EBITDA as defined less debt interest payments, CapEx and cash taxes, we expect this metric to be in the $800 million to $900 million area, maybe a little better during fiscal ‘21. However, the actual cash balance over the course of the year should increase by $400 million to $600 million, and the actual cash balance grows by less than the free cash flow from operations because it is reduced by term loan amortization, paybacks, a potential uptick in net working capital investment assuming we do see a commercial aftermarket uptick later in the year, small product line acquisitions at some of our business units in delayed cash severance payouts related to the COVID-19 reductions in force and a few of our European OP units. As you know, we aim to issue guidance that in time proves to be conservative. From an overall cash liquidity and balance sheet standpoint, we think we remain in good position here and well prepared to withstand the currently depressed commercial environment for quite some time. With that, I’ll turn it back to the operator to kick off the Q&A.

Your first question comes from Kristine Liwag with Morgan Stanley. You may now ask your question.

Hi. Good morning, everyone.

Good morning.

Good morning.

With the cost takeout that you’ve done last quarter on SG&A and the repositioning actions you’ve taken so far, can you provide more color about how much of this cost do you think you can keep as volumes recover? And ultimately, how should we think about incremental margins of aerospace recover?

I’ll take that, first. I think incremental margins as we guided would – we believe they will continue to improve during the year. I think that’s important to note, but dependent on aerospace recovery and people continuing to fly, is there a second wave? Is that a concern that slows us down? I think all of these factors will weigh in. But right now we anticipate things will continue to improve. We will make the most. I’ve said this before on our earnings calls, and I’ll say it again. We will make the most of the opportunity of whatever revenue comes our way in this lumpy recovery that we’re seeing and we will make the most of it. We just don’t see enough visibility to give more clarity on the go forward.

Thanks. And maybe one clarifying question. When you had the $400 million-plus in cash generation on your slide, and then right with the commentary on an $800 million to $900 million in fiscal year 2021, can you bridge the two? What’s the difference in the definition of what’s on the slide versus your defined free cash flow?

Yes. It’s Mike. The disconnect between the actual cash build to the balance sheet of $400 million to $600 million versus the cash from ops of $800 million to $900 million is just some assumptions around a couple of different things. First, just net working capital build. We’ve had a benefit here as cash has come out of working – cash has come out of accounts receivable. But as we go into the recovery, that’s going to go back in and become a source of cash. We’ve baked in some product line acquisitions too at a couple of our OP units. And there are some severance payments that European OP units related to the COVID reductions in force where we simply have taken the accrual, but we haven’t made the cash payout yet. Hopefully, all those assumptions in those bridging items proved to be conservative in time. We think the amount we put into the estimates what I provided today is a little conservative, but we’ll see.

Thank you.

I think there was also an earlier part of your question, which was about how many heads will we bring back and costs will return. And I’ll say the same point on that that we’ve made many times. And I think similar to what Nick has said in the past is, we will bring heads back as the volume dictates, but in a very reduced manner. We will be stringent on that and ensure that we bring cost back in a very slow and timely manner, so that we don’t let things run away.

And I would think when the dust settles and everything normalizes, we’ll likely come out the end of this with an improved cost structure, absolutely.

Thank you for the color, guys.

Your next question comes from Myles Walton with UBS. You may ask your question.

Good morning. This is actually Lou on for Myles.

Good morning.

Good morning.

Can you just give us a little bit more of the assumptions you have built into the 44% EBITDA margin? I know you sort of – it assumes the aftermarket, I guess, recovery starts in the second-half? And you’ve got the mid-single-digit growth and in OE. Are you sort of expecting this minus 40-plus percent to continue through 2021, or just any additional color on those assumptions?

Go ahead.

Yes. I think the assumptions driving the 44% for the first-half of the year roughly assume the current environment to sort of what we’ve been seeing for the past six months. And then we put in an uptick, as Nick mentioned, in the back-half of the year. The defense forecast should be as we mentioned. On the commercial OE side, we do expect it to be down for the first two quarters sequentially versus last year and the aftermarket as well. And then a modest uptick in the back-half of the year on commercial aftermarket.

I think the best way to follow this is to look at the flight take off and landings. And as we’ve seen them increase, we’re at about 50% of where we were globally. I think that’s the way to follow. We need people flying. We need planes taking off and landing, that’s what generates aftermarket content and that’s what we need to follow. And right now that’s largely plateauing with this second wave. We’ll see how this comes – how this changes over the next couple of months with this – the advent of a vaccine.

Okay, great. And then just one quick model; is there any backlog amortization expected this year? I think you have $50 million or so this year again in 2020?

De minimis.

No. I think it’s de minimis this year. That was mainly just from the acquisition of Esterline rolled out now.

Okay, great. Thank you.

Your next question comes from Carter Copeland with Melius Research. You may ask your question.

You don’t read that one every day. There you go.

Yes. I know where you work though.

I like it. Nick, I’m sorry to hear about, Doug. You guys really built something amazing and that’s sad news. So apologies about that, but…

Thanks.

Thanks.

Kevin, I wondered if you could talk about a couple of things. One of them just stocking dynamics, if there is anything unique that you’re seeing across the product lines or in particular geographies or customer sets. Just anything to be aware of in terms of inventory in the channel or buying behaviors anything like that we should be aware of.

Clearly inventory in the channel is something to consider. We don’t get a lot of visibility on inventory in the channel with OEM partners or airlines. It is largely unknown. What we do know is our distribution partners and I will tell you that their POS is running in line with our performance. So they are very much in lockstep and very much in lockstep with takeoff and landings. So we’re seeing that come together. What was the rest of the question? Repeat that, Carter.

Just in terms of both products and geographies, if there is anything…

Yes.

Anything?

Yes. Geographies, Carter, we don’t comment on. It’s hard for us to see geographies anyway because of the way our products are sold either through OEMs or airlines or distribution partners. We don’t see much on the geography side. I know in talking to our partners in Asia, the distribution partners there that we have that they are seeing an uptick. They are seeing more consumption because of the domestic business that has now returned to largely the same internal China flight metrics as before. So that continues to be good performance geographically. That’s probably the only color I can give you is the things appear to be improving, although at a conservative rate there. I think the lack of international flight activity is certainly slowing that business down. But I think the piece – we’ve touched on USM in the past and how that’s not a big driver for us. I think the only piece you have to keep in mind is the amount of inventory that may be present is dependent on our sales process and philosophy. We do not give volume discounts to the field. So there is going to be less available inventory as some people may give volume discounts. If you buy 100 pieces, you might save something. We don’t do that at all. It’s one of the things that we look to remove on acquisitions. So that’s something to keep in mind.

Okay. And then, just a quick follow-up. I think you’ll be below the hurdle for some of the interest deductibility, just given the income, I think, that implied for next year. Does that put any emphasis on getting a deal done in capital deployment? Or is it just de minimis in the impact?

I think it’s de minimis. You’re right on the math there. We are slightly above it. We got a lot of a benefit just from the Cares Act expansion and deduction to 50% of the US EBITDA. But I don’t think that factors into any of the capital allocation or M&A thinking.

Yes, okay.

Carter, you know we go through at least M&A allocation. You know, I can’t imagine that calculation would materially change our return.

Yes.

It surely wouldn’t change judgments on the individual businesses.

Okay. Thanks for the color, guys. And keep up the good work.

Thanks, Carter.

Your next question comes from David Strauss with Barclays. You may now ask your question.

Thanks. Good morning, everyone. So, Mike just going back to this cash generation block. Just to put a finer point on it. So it looks like working capital was maybe $200 million positive this year. Are you assuming that, that reverses in a similar fashion next year and how it looks?

Yes, we’re assuming a chunk of it reverses, yes. If you peel the onion back a little bit, you would see, accounts receivable was basically a source of cash for us of about $350 million; it was down 36% or so on the year. That was just driven by the commercial end market declines in the fact that we’ve been driving collections from the customers. So the sales drop provided you keep collecting in 57 days, which is about our average. Your accounts receivable sort of resets to your current sales level; that amount of cash is, obviously when we get back up to – and the commercial markets fully recovered. The $350 million is going to have to go back in, but the pace at which that happens is really uncertain depends how quickly recovery happens, the quicker it is, the sooner we’ll see that being a source of capital source of cash usage. But we’ve baked in some conservatism here into the forecast, because we frankly don’t want to give you guys the target just doesn’t take that into consideration and ends up being too high.

And I think assuming it’s appropriate, we’d love to see the receivables run up because that means the market is picking up.

It’s fair. And then cash taxes maybe $5,000 million or higher than that. What does that assume for the payroll tax deferral? You’re going to take care of that next year, or is that a beginning of the ‘22 item?

Yes, we’ll take care of it this year. The cash taxes should be somewhere in, as we model that we expect something north of $100 million, but not above $200 million. Again it depends on the pace of the recovery. It’s just really uncertain obviously and hard to forecast.

Okay. And then last one, on leverage. Mike, you talked about it’s going to – your net leverage will go up here. It looks like it will peak out maybe around eight times, somewhere in that range. I guess, how are you guys thinking about where you want your net leverage to be kind of when things start recovering and get back to normal given, we’ve got an even lower interest rate environment today than when we came into this? Thanks.

Yes. If you look back over the past say three years, pre-COVID, our average net debt to EBITDA was about almost exactly 6.0 times. I don’t think we have any inclination to change that once things reset. It’s obviously going to tick up a bit here and your math is correct. With the current run rating it slightly over eight times. Net debt to EBITDA were currently at 6.8 because we have two pre-COVID quarters and the LTM EBITDA computation. But I think coming out of this thing, the views on where we are comfortable operating the business from a leverage standpoint won’t change from what you saw three years ago that average period pre-COVID.

All I’d add is that specific calls on capital allocation and leverage levels as they may be comes around acquisition opportunities. You know; as you know, if we saw the right opportunity and felt comfortable with the market situation, we’d be willing to get up above that six on a steady state, but generally it then rests back down.

All right. Thanks very much.

Your next question comes from Robert Spingarn with Credit Suisse. You may now ask your question.

Hi, good morning. Kevin, on the M&A pipeline, is it still the way you’ve described it previously, a lot of defense properties against commercial properties maybe being a bit overpriced in this environment. And do you think the prospect of maybe better recovery visibility with this vaccine news changes that dynamic at all?

I’ll take a crack at that. The answer is yes, more defense and we’re not seeing quality commercial businesses hardly at all. So what we tend to be seeing is defense. And I just don’t know how to speculate, but I would suspect, if you start to get a robust recovery people will become more willing to sell. It’s just tough to get a valuation around something now, right.

Okay.

Our valuation, anybody is going to like.

Right. And then, just as a follow-up on the defense with the big sequential growth and it being 43% of the current sales profile, we know that will change with the recovery, but what are the – and OE, I guess growing a bit stronger than aftermarket. What are the main platforms that are driving us?

On the defense side?

Yes.

I think it’s F-35, APKWS is a major program for us. It hits several platforms. But beyond that we’re nicely market weighted to the key opportunities. I can hit on a couple of some parachutes business here or there that’s important to us. But we’re market weighted on platforms. But I ticked off to it, APKWS and F-35 that immediately come to mind.

Okay.

And Rob, as you know, we’re on most of the freighters, most of the operators, most of the helicopters across sort of the US defense fleet and then many of the European ones.

Yes. I thought it was interesting though your comment on OE versus aftermarket. So that prompted the question.

Got it.

Thank you.

Your next question comes from Noah Poponak with Goldman Sachs. You may now ask your question.

Hi. Good morning, everybody. I just wanted to stay on defense actually for a second. The 2021 will have a pretty easy comparison given the low growth rate in 2020. And given an approximation of what your pricing power is in that business to be low single, I think units would have to be negative. And just given outlays will still be growing, given the easy comp you have there, given the pricing power. How would you get to low single? Is there any programmatic headwind following up to that last question?

Yes. I would say, hopefully we’re conservative in our approach. We don’t know of any headwind necessarily. It’s interesting that you know low growth rate in 2020, but that’s – historically that’s been right where we historically our 0% to 1% or 2%. So low given where we were over the last couple of years, but historically in line. So we don’t really see it so low, but there is more opportunity, as we go into ‘21, we have a strong order book. You saw the way we closed the year with very strong bookings in the fourth quarter. I think we’re in a good position. It’s just – can we get it out and do they want to receive it per the original order schedule.

Okay.

I think the OEM business other than inventory switches – inventory movements in defense going to change a lot, that we assume. On the other hand, the aftermarket business in defense is not booked out.

Yes. You could easily see some swings down, I wouldn’t think it would be dramatic, or up in that. I mean that’s where the movement could be.

I'm showing no further questions at this time. I would like to turn the conference back to Jaimie Stemen.

Thank you all for joining us today. This concludes today’s call. We appreciate your time. And again, thanks for joining us today.

Ladies and gentlemen, this concludes today’s conference. Thank you for your participation, and have a wonderful day. You may all disconnect.